Nerea Zabaleta

Nerea Zabaleta

Harvard University

H-index: 11

North America-United States

About Nerea Zabaleta

Nerea Zabaleta, With an exceptional h-index of 11 and a recent h-index of 11 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Gene therapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1

Tracing the fate of AAV vectors in the body

Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate

Gene therapy for liver diseases—Progress and challenges

Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice

Ancestral library identifies conserved reprogrammable liver motif on AAV capsid

Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques

Review 1:" Accelerated Waning of the Humoral Response to SARS-CoV-2 Vaccines in Obesity"

Nerea Zabaleta Information

University

Position

Mass. Eye and Ear - Harvard Medical School

Citations(all)

573

Citations(since 2020)

559

Cited By

137

hIndex(all)

11

hIndex(since 2020)

11

i10Index(all)

11

i10Index(since 2020)

11

Email

University Profile Page

Google Scholar

Nerea Zabaleta Skills & Research Interests

Gene therapy

Top articles of Nerea Zabaleta

Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1

EMBO Molecular Medicine

2024/1/16

Tracing the fate of AAV vectors in the body

Nature Biotechnology

2023/11/27

Nerea Zabaleta
Nerea Zabaleta

H-Index: 6

Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate

Molecular Therapy-Methods & Clinical Development

2023/9/14

Gene therapy for liver diseases—Progress and challenges

2023/5

Nerea Zabaleta
Nerea Zabaleta

H-Index: 6

Carmen Unzu
Carmen Unzu

H-Index: 8

Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice

Nature medicine

2023/2

Aditya Raguram
Aditya Raguram

H-Index: 7

Nerea Zabaleta
Nerea Zabaleta

H-Index: 6

Ancestral library identifies conserved reprogrammable liver motif on AAV capsid

Cell Reports Medicine

2022/11/15

Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques

Molecular Therapy

2022/9/7

Review 1:" Accelerated Waning of the Humoral Response to SARS-CoV-2 Vaccines in Obesity"

Rapid Reviews Infectious Diseases

2022/9/4

mRNA and gene editing: Late breaking therapies in liver diseases

2022/9/1

Nerea Zabaleta
Nerea Zabaleta

H-Index: 6

Immunogenicity of an AAV-Based COVID-19 vaccine in murine models of obesity and aging

Viruses

2022/4/15

Computed tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates

Iscience

2022/4/15

Yoann Aldon
Yoann Aldon

H-Index: 10

Nerea Zabaleta
Nerea Zabaleta

H-Index: 6

AAVCOVID: A single-dose, thermostable COVID-19 vaccine with durable immunogenicity

Topics in Antiviral Medicine

2022

Nerea Zabaleta
Nerea Zabaleta

H-Index: 6

Single-Dose Optimized AAV-Based COVID-19 Vaccine Elicits Durable and Protective Immunity Against Variants of Concern in Nonhuman Primates

Molecular Therapy

2022

Novel vectors and approaches for gene therapy in liver diseases

2021/8/1

Nerea Zabaleta
Nerea Zabaleta

H-Index: 6

AdrA as a potential immunomodulatory candidate for STING-mediated antiviral therapy that required both type I IFN and TNF-α production

The Journal of Immunology

2021/1/15

Nerea Zabaleta
Nerea Zabaleta

H-Index: 6

Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mouse and non-human primates

bioRxiv

2021/1/5

Biodistribution and Antigen Expression Kinetics of AAVCOVID Vaccine in Mice

Molecular Therapy

2021

Nerea Zabaleta
Nerea Zabaleta

H-Index: 6

Dan Li
Dan Li

H-Index: 10

Immunogenicity of Two AAV-Based COVID-19 Vaccine Candidates in Mouse Models of Aging and Obesity

Molecular Therapy

2021

Candidate Selection in BALB/c Mice towards a Single Dose AAV-Based COVID19 Prophylactic Vaccine

Molecular Therapy

2021

In vitro and in vivo genetic disease modeling via NHEJ-precise deletions using CRISPR-Cas9

Molecular Therapy-Methods & Clinical Development

2020/12/11

Nerea Zabaleta
Nerea Zabaleta

H-Index: 6

See List of Professors in Nerea Zabaleta University(Harvard University)